Title : Novel strategies to target chemoresistant triple-negative breast cancer.

Pub. Date : 2020 Dec 31

PMID : 33488948






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 TNBC cells treated with CFM-4.16 plus cisplatin inhibited the expression of FZD8, LRP6 and c-Myc and significantly enhanced cell death in all the cell lines by ~70%-80% compared with the control(s). Cisplatin MYC proto-oncogene, bHLH transcription factor Homo sapiens